• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    India Globalization Capital Inc (NY: IGC )

    0.4010 -0.0125 (-3.02%)
    Official Closing Price Updated: 8:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 203,923
    Open 0.4393
    Bid (Size) 0.4011 (5)
    Ask (Size) 0.4280 (74)
    Prev. Close 0.4135
    Today's Range 0.4010 - 0.4450
    52wk Range 0.2501 - 0.9099
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
    From IGC Pharma, Inc.
    Via Business Wire

    Performance

    YTD
    +45.29%
    +45.29%
    1 Month
    -25.62%
    -25.62%
    3 Month
    +6.03%
    +6.03%
    6 Month
    +29.23%
    +29.23%
    1 Year
    +35.89%
    +35.89%

    More News

    Read More
    Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
    Via Benzinga
    Topics Cannabis Regulatory Compliance
    Exposures Cannabis Legal Regulatory
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
    From IGC Pharma, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Initiates Patient Enrollment in Phase 2 Trial Investigating IGC-AD1
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
    From IGC Pharma Inc.
    Via Business Wire
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Management Hosting Meetings at Upcoming BIO International Convention 2024
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma to Attend BIO International Convention 2024
    From IGC Pharma Inc.
    Via Business Wire
    6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
    Via News Direct
    6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
    Via TheNewswire.com
    Topics Cannabis
    Exposures Cannabis Product Safety
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Shares Positive Interim Results on IGC-AD1 for Agitation in Alzheimer’s
    Via Investor Brand Network
    Topics Artificial Intelligence Cannabis
    Exposures Artificial Intelligence Cannabis
    IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
    Via Benzinga
    IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
    From IGC Pharma, Inc.
    Via Business Wire
    Who's Who In Cannabis: Latest Executive Changes You Should Know About
    Via Benzinga
    BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Adds AI Expert to Support Development of Phase 2 Clinical Trial
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma Adds Advisor in Artificial Intelligence
    From IGC Pharma, Inc.
    Via Business Wire
    IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research
    Via News Direct
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.